원바이오젠
307280KOSDAQ· 의료용 물질 및 의약품 제조업5,970원-20 (-0.33%)지연장중 · 갱신 대기
52주 위치
4,7658,40033%신고가 대비 -28.93%
- 시가총액
- 424억
- PER
- 4.93
- PBR
- 0.95
- EPS(TTM)
- 1,210원
- BPS
- 6,310원
- 배당수익률
- 2.35%
- 자사주비율
- 4.07%
- 결산월
- 12월
알림 만들기관심종목·메모·논지·저널은 로그인하면 사용 가능
| 항목 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| ROE | -2.48% | 12.26% | 18.62% | 16.39% | 16.55% |
| ROA | -1.73% | 8.50% | 14.57% | 12.69% | 14.53% |
| 영업이익률 | 11.51% | 19.26% | 24.05% | 21.05% | 22.49% |
| 순이익률 | -3.72% | 12.23% | 20.13% | 17.54% | 18.33% |
| 매출총이익률 | 42.86% | 46.60% | 47.93% | 46.91% | 50.55% |
| 부채비율 | 43.23% | 45.13% | 31.51% | 10.74% | 11.73% |
| 유동비율 | 210.02% | 157.16% | 226.14% | 654.85% | 600.09% |
| 매출 성장률(YoY) | — | 50.94% | 10.72% | 2.79% | 15.78% |
| 영업이익 성장률(YoY) | — | 152.50% | 38.30% | -10.05% | 23.72% |
| 순이익 성장률(YoY) | — | — | 82.15% | -10.44% | 20.99% |
| FCF | -12.54억 | -7.12억 | 31.89억 | 82.01억 | 65.12억 |
| FCF 마진 | -7.08% | -2.66% | 10.77% | 26.94% | 18.48% |
| CAPEX/매출 | 13.18% | 24.28% | 5.56% | 2.13% | 5.59% |
| 항목 | 2021 3Q | 2021 4Q | 2022 1Q | 2022 2Q | 2022 3Q | 2022 4Q | 2023 1Q | 2023 2Q | 2023 3Q | 2023 4Q | 2024 1Q | 2024 2Q | 2024 3Q | 2024 4Q | 2025 1Q | 2025 2Q | 2025 3Q | 2025 4Q | 2026 1Q | 2026 2Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 1.76% | 1.49% | 2.93% | 3.41% | 5.99% | 0.15% | 5.58% | 8.35% | 2.22% | 5.03% | 3.49% | 5.08% | 4.25% | 4.58% | 3.54% | 4.36% | 5.65% | 3.98% | 4.19% | 7.10% |
| ROA | 1.51% | 1.04% | 2.03% | 2.33% | 4.59% | 0.11% | 3.83% | 5.78% | 1.61% | 3.63% | 2.46% | 3.70% | 3.11% | 3.19% | 2.89% | 3.29% | 4.83% | 3.47% | 4.01% | 5.74% |
| 영업이익률 | 10.28% | 7.82% | 17.29% | 20.82% | 24.77% | 13.01% | 23.58% | 26.10% | 23.30% | 23.88% | 16.70% | 25.62% | 24.49% | 17.59% | 18.57% | 22.54% | 26.01% | 22.43% | 22.82% | 27.99% |
| 순이익률 | 9.53% | 7.27% | 11.43% | 11.96% | 22.85% | 0.73% | 19.98% | 31.03% | 9.23% | 20.15% | 14.73% | 20.30% | 19.63% | 15.77% | 15.17% | 17.24% | 24.02% | 16.48% | 20.05% | 28.21% |
| 매출총이익률 | 41.14% | 48.98% | 42.73% | 47.09% | 51.05% | 45.38% | 44.75% | 52.05% | 47.00% | 48.86% | 43.15% | 50.83% | 51.09% | 42.99% | 45.22% | 51.77% | 53.24% | 51.50% | 50.02% | 52.72% |
| 부채비율 | 17.14% | 43.23% | 44.59% | 46.28% | 43.08% | 45.13% | 46.78% | 42.86% | 32.90% | 31.51% | 32.22% | 27.99% | 26.91% | 10.74% | 13.88% | 11.53% | 11.10% | 11.73% | 18.32% | 20.61% |
| 유동비율 | 411.79% | 210.02% | 201.88% | 156.75% | 164.95% | 157.16% | 160.85% | 177.89% | 206.50% | 226.14% | 225.49% | 273.52% | 291.61% | 654.85% | 514.60% | 578.02% | 598.21% | 600.09% | 431.10% | 324.83% |
| 매출 성장률(YoY) | — | — | — | — | 46.35% | 3.76% | 10.30% | 3.54% | 1.59% | 30.52% | -8.62% | 6.66% | -1.28% | 15.42% | 16.74% | 5.02% | 34.33% | 10.15% | 12.43% | 18.26% |
| 영업이익 성장률(YoY) | — | — | — | — | 252.60% | 72.49% | 50.39% | 29.81% | -4.44% | 139.66% | -35.28% | 4.68% | 3.76% | -15.00% | 29.83% | -7.61% | 42.67% | 40.50% | 38.13% | 46.89% |
| 순이익 성장률(YoY) | — | — | — | — | 250.85% | -89.62% | 92.85% | 168.62% | -58.96% | 3515.02% | -32.63% | -30.24% | 110.00% | -9.68% | 20.19% | -10.77% | 64.36% | 15.08% | 48.65% | 93.45% |
| FCF | -4.97억 | -4.39억 | -1.51억 | -22.93억 | 11.66억 | 5.66억 | 16.26억 | 9.15억 | -1.7억 | 8.18억 | 22.16억 | 16.47억 | 20.08억 | 23.3억 | 8.86억 | 18.02억 | 20.91억 | 17.32억 | -22.2억 | -30.92억 |
| FCF 마진 | -10.64% | -8.06% | -2.15% | -31.67% | 17.04% | 10.01% | 21.01% | 12.21% | -2.45% | 11.09% | 31.34% | 20.60% | 29.26% | 27.38% | 10.73% | 21.47% | 22.68% | 18.48% | -23.92% | -31.13% |
| CAPEX/매출 | 19.90% | 20.46% | 16.56% | 48.09% | 15.86% | 13.55% | 4.52% | 2.74% | 5.40% | 9.70% | 3.88% | 2.20% | 0.40% | 2.00% | 4.92% | 2.31% | 10.34% | 4.46% | 52.58% | 57.72% |
출처 DART 재무제표 원값으로 자체 계산· 갱신 2026-09-21 00:25· 연결·별도 혼합 · 산식은 항목 툴팁